Protagonist Therapeutics (PTGX) Cash flow

736 Followers

Protagonist Therapeutics Cash Flow

PTGX's free cash flow for Q4 2025 was $-35.53M. For the 2025 fiscal year, PTGX's free cash flow was decreased by $-126.72M and operating cash flow was $-36.98M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 57.67M	$ 184.15M	$ -70.24M	$ -108.14M	$ -107.86M
Investing Cash Flow	$ -49.33M	$ -299.48M	$ -39.26M	$ 91.47M	$ -15.86M
Financing Cash Flow	$ 22.86M	$ 25.85M	$ 170.48M	$ 18.84M	$ 129.92M
End Cash Position	$ 128.39M	$ 97.47M	$ 186.95M	$ 125.97M	$ 123.89M
Free Cash Flow	$ 56.08M	$ 182.80M	$ -70.84M	$ -108.93M	$ -108.97M

Currency in USD